Your browser doesn't support javascript.
loading
Adipose glucocorticoid action influences whole-body metabolism via modulation of hepatic insulin action.
Abulizi, Abudukadier; Camporez, João-Paulo; Jurczak, Michael J; Høyer, Kasper F; Zhang, Dongyan; Cline, Gary W; Samuel, Varman T; Shulman, Gerald I; Vatner, Daniel F.
Afiliación
  • Abulizi A; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Camporez JP; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Jurczak MJ; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Høyer KF; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Zhang D; Department of Clinical Medicine, Magnetic Resonance Research Centre, Aarhus University, Aarhus, Denmark.
  • Cline GW; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Samuel VT; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Shulman GI; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Vatner DF; Veterans Affairs Medical Center, West Haven, Connecticut, USA.
FASEB J ; 33(7): 8174-8185, 2019 07.
Article en En | MEDLINE | ID: mdl-30922125
ABSTRACT
The connection between adipose glucocorticoid action and whole-body metabolism is incompletely understood. Thus, we generated adipose tissue-specific glucocorticoid receptor-knockout (Ad-GcR-/-) mice to explore potential mechanisms. Ad-GcR-/- mice had a lower concentration of fasting plasma nonesterified fatty acids and less hepatic steatosis. This was associated with increased protein kinase B phosphorylation and increased hepatic glycogen synthesis after an oral glucose challenge. High-fat diet (HFD)-fed Ad-GcR-/- mice were protected against the development of hepatic steatosis and diacylglycerol-PKCε-induced impairments in hepatic insulin signaling. Under hyperinsulinemic-euglycemic conditions, hepatic insulin response was ∼10-fold higher in HFD-fed Ad-GcR-/- mice. Insulin-mediated suppression of adipose lipolysis was improved by 40% in Ad-GcR-/- mice. Adipose triglyceride lipase expression was decreased and insulin-mediated perilipin dephosphorylation was increased in Ad-GcR-/- mice. In metabolic cages, food intake decreased by 3 kcal/kg per hour in Ad-GcR-/- mice. Therefore, physiologic adipose glucocorticoid action appears to drive hepatic lipid accumulation during stressors such as fasting. The resultant hepatic insulin resistance prevents hepatic glycogen synthesis, preserving glucose for glucose-dependent organs. Absence of adipose glucocorticoid action attenuates HFD-induced hepatic insulin resistance; potential explanations for reduction in hepatic steatosis include reductions in adipose lipolysis and food intake.-Abulizi, A., Camporez, J.-P., Jurczak, M. J., Høyer, K. F., Zhang, D., Cline, G. W., Samuel, V. T., Shulman, G. I., Vatner, D. F. Adipose glucocorticoid action influences whole-body metabolism via modulation of hepatic insulin action.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Resistencia a la Insulina / Tejido Adiposo / Glucocorticoides / Insulina / Lipólisis / Hígado Límite: Animals Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Resistencia a la Insulina / Tejido Adiposo / Glucocorticoides / Insulina / Lipólisis / Hígado Límite: Animals Idioma: En Año: 2019 Tipo del documento: Article